Revenue (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|---|---|
Jun. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Revenue (Details) [Line Items] | |||||||
Vehicle lease totaled | $ 126,111 | $ 378,333 | $ 378,333 | $ 1,153,000 | $ 378,333 | ||
Accounts receivable | 637,350 | $ 794,136 | |||||
Allowances for doubtful | 17,827 | 17,827 | 0 | ||||
Debt expense | $ 0 | 17,827 | 0 | ||||
Contract assets decreased | $ 409,431 | ||||||
Contract liabilities | 306,791 | ||||||
Revenue recognized | $ 67,000 | ||||||
Revenue recognize | $ 11,500,000 | ||||||
Forecast [Member] | |||||||
Revenue (Details) [Line Items] | |||||||
Vehicle lease totaled | $ 378,333 | ||||||
Vehicle Lease [Member] | |||||||
Revenue (Details) [Line Items] | |||||||
Vehicle lease totaled | $ 2,270,000 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount paid to revenue recognize. No definition available.
|
X | ||||||||||
- Definition Amount of increase from purchase of accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of allowance for credit loss on receivable, classified as other and current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of decrease from sale of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time and other income. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of revenue recognized that was previously reported as deferred or unearned revenue. No definition available.
|
X | ||||||||||
- Definition Interest and debt related expenses associated with nonoperating financing activities of the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|